Tag: CTN-0062-Ot-A1
October 26, 2017
Northeast Node travels to Maine to begin Phase 1 of CTN trial with partner organization
In early October, the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network traveled to its partner network, Penobscot Community Health Care (PCHC), in Bangor, Maine, to collect qualitative data for Phase 1 of the CTN-0062-Ot-A1 study, “Implementing the Tobacco, Alcohol, Prescription medication, and Substance use/misuse (TAPS) Tool in rural federally-qualified health centers: An ancillary study of the “CDE-EHR-PC” (CTN-0062-Ot) Study.”
July 19, 2017
Maine partner named as new site in Greater New York Node CTN study
Alcohol and drug use disorders are among the top ten causes of preventable death in the United States, and only a small fraction of individuals with unhealthy substance use are served by the specialty addiction treatment system.(1-4) People with substance use disorders (SUDs) are rarely screened, assessed or treated in mainstream healthcare settings such as primary care clinics and other office-based practices. While mainstream settings represent an ideal place and context to identify SUDs and initiate treatment, efforts to integrate SUD services have largely fallen short.